KR20140048237A - 플루티카손 프로피오네이트 형태 1의 제조 방법 - Google Patents

플루티카손 프로피오네이트 형태 1의 제조 방법 Download PDF

Info

Publication number
KR20140048237A
KR20140048237A KR1020147003035A KR20147003035A KR20140048237A KR 20140048237 A KR20140048237 A KR 20140048237A KR 1020147003035 A KR1020147003035 A KR 1020147003035A KR 20147003035 A KR20147003035 A KR 20147003035A KR 20140048237 A KR20140048237 A KR 20140048237A
Authority
KR
South Korea
Prior art keywords
fluticasone propionate
solvent
solution
slurry
propionate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147003035A
Other languages
English (en)
Korean (ko)
Inventor
마르틴 데이빗 티세허르스트
이반 마르지아노
엘레프테리오스 코우고울로스
Original Assignee
화이자 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 리미티드 filed Critical 화이자 리미티드
Publication of KR20140048237A publication Critical patent/KR20140048237A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020147003035A 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법 Ceased KR20140048237A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161505612P 2011-07-08 2011-07-08
US61/505,612 2011-07-08
PCT/US2012/045660 WO2013009591A1 (en) 2011-07-08 2012-07-06 Process for the preparation of fluticasone propionate form 1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020197026105A Division KR102163368B1 (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법

Publications (1)

Publication Number Publication Date
KR20140048237A true KR20140048237A (ko) 2014-04-23

Family

ID=47506422

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020147003035A Ceased KR20140048237A (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법
KR1020207028182A Ceased KR20200117056A (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법
KR1020197026105A Expired - Fee Related KR102163368B1 (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020207028182A Ceased KR20200117056A (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법
KR1020197026105A Expired - Fee Related KR102163368B1 (ko) 2011-07-08 2012-07-06 플루티카손 프로피오네이트 형태 1의 제조 방법

Country Status (10)

Country Link
US (2) US10370402B2 (cg-RX-API-DMAC7.html)
EP (1) EP2729480A4 (cg-RX-API-DMAC7.html)
JP (2) JP2014520848A (cg-RX-API-DMAC7.html)
KR (3) KR20140048237A (cg-RX-API-DMAC7.html)
CN (2) CN103649104A (cg-RX-API-DMAC7.html)
AU (1) AU2012282936B2 (cg-RX-API-DMAC7.html)
CA (1) CA2840401C (cg-RX-API-DMAC7.html)
MX (2) MX376564B (cg-RX-API-DMAC7.html)
WO (1) WO2013009591A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201309531B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX376564B (es) * 2011-07-08 2025-03-07 Pfizer Ltd Proceso para la preparación de la forma 1 del propionato de fluticasona.
ES2727474T3 (es) 2012-05-08 2019-10-16 Nicox Ophthalmics Inc Nanocristales de propionato de fluticasona
US9796750B2 (en) 2014-02-07 2017-10-24 Mylan Laboratories Ltd. Process for the purification of fluticasone propionate using a ketone solvent and water as anti-solvent
CN111662353A (zh) * 2019-03-05 2020-09-15 上海谷森医药有限公司 一种糠酸氟替卡松晶型1的制备方法
US20220168665A1 (en) * 2019-04-10 2022-06-02 Eupraxia Pharmaceuticals Inc. Process for making drug crystals of desired size distribution and morphology
CN110759960B (zh) * 2019-10-30 2021-03-23 山东赛托生物科技股份有限公司 一种丙酸氟替卡松的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2088877B (en) 1980-02-15 1984-07-04 Glaxo Group Ltd Androstane 17 carbothioates
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
SE9501384D0 (sv) * 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
GB0015981D0 (en) * 2000-06-29 2000-08-23 Glaxo Group Ltd Novel process for preparing crystalline particles
GB0125604D0 (en) * 2001-10-25 2001-12-19 Glaxo Group Ltd Novel process
GB0201400D0 (en) * 2002-01-22 2002-03-13 Glaxo Group Ltd Novel apparatus and process
GB0202564D0 (en) * 2002-02-04 2002-03-20 Glaxo Group Ltd Process
AU2003263575A1 (en) * 2002-06-20 2004-01-06 Sun Pharmaceutical Industries Limited Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate
GB0315509D0 (en) 2003-07-02 2003-08-06 Meridica Ltd Dispensing device
US7314516B2 (en) * 2004-12-29 2008-01-01 Five Star Technologies, Inc. Hydrodynamic cavitation crystallization device and process
MX376564B (es) * 2011-07-08 2025-03-07 Pfizer Ltd Proceso para la preparación de la forma 1 del propionato de fluticasona.

Also Published As

Publication number Publication date
MX2014000192A (es) 2014-04-25
US20200024298A1 (en) 2020-01-23
AU2012282936B2 (en) 2016-11-10
MX2020011330A (es) 2020-11-24
ZA201309531B (en) 2014-08-27
CA2840401C (en) 2016-05-17
JP2017031161A (ja) 2017-02-09
CA2840401A1 (en) 2013-01-17
WO2013009591A1 (en) 2013-01-17
CN103649104A (zh) 2014-03-19
MX376564B (es) 2025-03-07
KR102163368B1 (ko) 2020-10-08
US20140141247A1 (en) 2014-05-22
CN106977575A (zh) 2017-07-25
US10370402B2 (en) 2019-08-06
KR20200117056A (ko) 2020-10-13
EP2729480A1 (en) 2014-05-14
AU2012282936A1 (en) 2014-01-16
KR20190107165A (ko) 2019-09-18
JP2014520848A (ja) 2014-08-25
EP2729480A4 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
US20200024298A1 (en) Process for the preparation of fluticasone propionate form i
JP4331619B2 (ja) 臭化チオトロピウムの結晶性微粒子
TW200302817A (en) New fluorenecarboxylic acid esters, process for the manufacture thereof and use thereof and use thereof as medicaments
AU2018303293B2 (en) Amorphous form of vilanterol trifenatate and processes for the preparation thereof
EA011157B1 (ru) Способ получения кристаллического циклесонида, обладающего определенным размером частиц
CN106163505B (zh) 可吸入颗粒相关改进
AU2017278484B2 (en) Crystalline pharmaceutical co-crystals of glycopyrronium bromide with lactose
US20100120737A1 (en) Amorphous ciclesonide
CN119925617A (zh) 一种用于治疗慢性阻塞性肺病(copd)的药物组合物及其制备方法
CN103130798B (zh) 噻托溴铵的结晶
CN110396101A (zh) 曲索芬头孢曲松钠药物制剂治疗细菌性内膜炎的新适应症
CN119970731A (zh) 一种含有沙美特罗和噻托铵盐组合物的吸入干粉制剂及其制备方法
ZA200506943B (en) Process for preparing cryalline ciclesonide with defined particle size
JP2021525230A (ja) ４−フェニルチアゾール誘導体の結晶形およびその調製方法
CN106880637A (zh) 一种环索奈德福莫特罗噻托溴铵复方干粉吸入剂组合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140205

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170705

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20181116

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190527

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20181116

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20190527

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20190116

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20170705

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20190806

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20190705

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20190527

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20190116

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20181116

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20170705

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20190905